Citigroup Starts Eli Lilly with a “Buy” Rating; Fiscal Cliff Sequestration Consequences Limited (LLY)

Share |

Citigroup initiated coverage on pharmaceutical company Eli Lilly & Co. ( LLY ) on Friday.

The analysts start LLY off with a "Buy" rating and a price target of $55, a +13% upside to Thursday's closing price of $48.58

The firm said that they believe the risks of sequestration due to the "fiscal cliff," meaning a cut to Medicare part D drug spending, would be small for LLY.

Eli Lilly shares were up 17 cents, or +0.35%, in premarket trading on Friday.

The Bottom Line
Shares of Eli Lilly ( LLY ) have a 4.03% dividend yield, based on last night's closing stock price of $48.58. The stock has technical support in the $44-$46 price area. If the shares can firm up, we see overhead resistance around the $51-$52 price levels.

Eli Lilly & Co. ( LLY ) is not recommended at this time, holding a DARS™ Rating of 3.4 out of 5 stars.

Be sure to visit our complete recommended list of the Best Dividend Stocks , as well as a detailed explanation of our ratings system here .

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.

Created by

This article appears in: Investing , Stocks

Referenced Stocks: LLY

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by